Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)

CNY 63.1

(1.25%)

Market Cap (In CNY)

28.39 Billion

Revenue (In CNY)

1.99 Billion

Net Income (In CNY)

644.17 Million

Avg. Volume

4.39 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
32.25-68.87
PE
-
EPS
-
Beta Value
0.576
ISIN
CNE100005XJ7
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Jinhao Du
Employee Count
-
Website
https://www.allist.com.cn
Ipo Date
2020-12-02
Details
Shanghai Allist Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in China. It offers pharmaceuticals for the treatment of tumor and cancer diseases. The company was founded in 2004 and is based in Shanghai, China.